Evidence map›Paper›PMID 28209996›Full record

ArticleScientific reports2017

Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice.

Emmanuel Dotsey, Irina Ushach, Egest Pone, Rie Nakajima, Algis Jasinskas, Donovan A Argueta, Andrea Dillon, Nicholas DiPatrizio, Huw Davies, Albert Zlotnik and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. International journal of molecular sciences · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Emmanuel DotseyDivision of Infectious Diseases, Department of Medicine, University of California Irvine, Irvine, CA, USA.
Irina UshachDivision of Infectious Diseases, Department of Medicine, University of California Irvine, Irvine, CA, USA.
Egest PoneDepartment of Pharmaceutical Sciences, University of California Irvine, Irvine, CA, USA.
Rie NakajimaDivision of Infectious Diseases, Department of Medicine, University of California Irvine, Irvine, CA, USA.
Algis JasinskasDivision of Infectious Diseases, Department of Medicine, University of California Irvine, Irvine, CA, USA.
Donovan A ArguetaDivision of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, USA.
Andrea DillonDivision of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, USA.
Nicholas DiPatrizioDivision of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, USA.
Huw DaviesDivision of Infectious Diseases, Department of Medicine, University of California Irvine, Irvine, CA, USA.
Albert ZlotnikDepartment of Physiology &Biophysics, University of California Irvine, Irvine CA, USA.
Peter D CromptonMalaria Infection Biology and Immunity Unit, Laboratory of Immunogenetics, NIAID, NIH, Rockville, MD, USA.
Philip L FelgnerDivision of Infectious Diseases, Department of Medicine, University of California Irvine, Irvine, CA, USA.
University of California, Irvine · USUniversity of California, Riverside · US

Funding

Mechanisms of naturally-acquired immunity to malaria and clinical trials of anti-malaria monoclonal antibodiesZIAAI001155 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI CROMPTON, PETER · 2011 to 2025
$30.9M
Predicting naturally acquired humoral immunity against malariaR01AI095916 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI FELGNER, PHILIP LOUIS · 2012 to 2016
$2.1M
A Role for Endocannabinoids in the Control of Dietary Fat IntakeR00DA034009 · NIDA · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI DIPATRIZIO, NICHOLAS VINCENT · 2015 to 2017
$857k
NIAID NIH HHS R01 AI095916NIDA NIH HHS R00 DA034009
6 · The paper itself

Abstract

The hallmark of vaccines is their ability to prevent the spread of infectious pathogens and thereby serve as invaluable public health tool. Despite their medical relevance, there is a gap in our understanding of the physiological factors that mediate innate and adaptive immune response to vaccines. The endocannabinoid (eCB) system is a critical modulator of homeostasis in vertebrates. Our results indicate that macrophages and dendritic cells produce the endocannabinoid, 2-arachidonoyl-sn-glycerol (2-AG) upon antigen activation. We have also established that 2-AG levels are upregulated in the serum and in the lymph node of mice during vaccination. We hypothesized that the intrinsic release of eCBs from immune cells during activation by pathogenic antigens mitigate inflammation, but also suppress overall innate and adaptive immune response. Here we demonstrate, for the first time, that transient administration of the cannabinoid receptor 2 antagonist AM630 (10 mg/kg) or inverse agonist JTE907 (3 mg/kg) during immunization heightens the intensity and breadth of antigen-specific immune responses in young and aged mice through the upregulation of immunomodulatory genes in secondary lymphoid tissues.

Indexed as

AnimalsAntibodies, MonoclonalArachidonic AcidsCannabinoidsDendritic CellsEndocannabinoidsFemaleGlyceridesImmunizationImmunomodulationImmunophenotypingIndolesMacrophage ActivationMacrophagesMiceReceptor, Cannabinoid, CB2Antibodies, MonoclonalArachidonic AcidsCannabinoidsEndocannabinoidsGlyceridesglyceryl 2-arachidonateIndolesiodopravadolineReceptor, Cannabinoid, CB2

Identifiers

PMID28209996
PMCPMC5314369
OpenAlexW2589100977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.